JUSTINA OBI: Open Payments
NPI 1801493671 · SAN BERNARDINO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,152 in 27 payments from 7 companies in 2025. Trend: 2023 $165 · 2024 $425 · 2025 $1,152
Food & beverage: $1,152
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 14 | $418 |
| Janssen Pharmaceuticals, Inc | 3 | $242 |
| Neurocrine BioSciences, Inc. | 3 | $165 |
| Otsuka America Pharmaceutical, Inc. | 4 | $143 |
| ABBVIE INC. | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 1 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
Products named: ARISTADA, INVEGA SUSTENNA, INGREZZA, VRAYLAR, LYBALVI, ABILIFY MAINTENA, VIVITROL, AUSTEDO XR.
Industry payments across CA — which companies pay providers there.
